Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ProstAtak
print preview
bookmark
share with colleague
General Information
Company
Advantagene Inc.
Description
Combination of vector AdV-tk (adenovirus thymidine kinase) and valacyclovir
Molecular Target
Mechanism of Action
Gene therapy
Latest Stage of Development
Phase II
Indication
Prostate cancer
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information